Correlation of tumor suppressor P53 RNA expression with human immunodeficiency virus disease in rapid and slow progressors

Journal of Human Virology

Volumn 1, Issue 1, 1997, Pages 30-36

  McLinden, Robert J ^a   Lewis, Bernadette ^a   Michael, Nelson L ^b   Redfield, Robert R ^a   Birx, Deborah L ^b   Kim, Jerome H ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

Apoptosis; HIV; P53

Indexed keywords

MESSENGER RNA; PROTEIN P53;

ANIMAL; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CELL CYCLE; CHO CELL; DISEASE COURSE; GENE EXPRESSION; GENETICS; HAMSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; SERODIAGNOSIS; TUMOR SUPPRESSOR GENE; VIROLOGY; VIRUS LOAD;

ANIMALS; CD4 LYMPHOCYTE COUNT; CELL CYCLE; CHO CELLS; CRICETINAE; DISEASE PROGRESSION; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; VIRAL LOAD;

EID: 0031261246     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Oyaizu N, Pahwa S. Role of apoptosis in HIV disease pathogenesis. J Clin Immunol 1995;15:217-231.
2. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992;257:217-219.
3. Laurent-Crawford AG, Krust D, Muller S, et al. The cytopathic effect of HIV is associated with apoptosis. Virology 1991;185:829-839.
4. + T cells from human immunodeficiency virusinfected asymptomatic individuals. J Exp Med 1992;175: 331-340.
5. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid Ieukaemic cells that is inhibited by ihterleukin-6. Nature 1991;352:345-347.
6. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-825.
7. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A 1995;92:8493-8497.
8. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tisty TD. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992;70: 923-935.
9. Levine AJ. P53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
10. Li CJ, Wang C, Friedman DJ, Pardee AB. Reciprocal modulations between P53 and Tat of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1995;92: 5461-5464.
11. Duan L, Ozaki I, Oakes JW, Taylor JP, Khalili K, Pomerantz RJ. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J Virol 1994;68:4302-4313.
12. Redfield RR, Birx DL, Ketter N, et al. HIV vaccine therapy phase I safety and immunogenicity evaluation of postinfection immune modification by active immunization with recombinant gp160. N Engl J Med 1991;324:1677-1684.
13. Michael NL, Chang G, Kim JH, Birx DL. Dynamics of cell-free viral burden in HIV-1-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:237-242.
14. Sarnow P, Ho YS, William J, Levine A. Adenovirus Elb-58 kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54-kd cellular protein in transformed cells. Cell 1982;28:387-394.
15. Wang EH, Friedman PN, Prives C. The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation function of SV40 large T antigen. Cell 1989; 57:379-392.
16. Duan L, Ozaki I, Oakes JW, Taylor JP, Khalili K, Pomerantz RJ. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J Virol 1994;68:4302-4313.
17. Li CJ, Wang C, Friedman DJ, Pardee AB. Reciprocal modulations between p53 and tat of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1995;92: 5461-5464.
18. Rogel ME, Wu LI, Emerman M. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J Virol 1995;69:882-888.
19. 2 + M phase of the cell cycle. J Virol 1995;69:6304-6313.
20. cdc2 activity. J Virol 1995;69:6705-6711.
21. Pandolfi F, Pierdominici M, Oliva A, et al. Apoptosisrelated mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr 1995;9: 450-458.
22. Meyaard L, Otto SA, Keet IPM, Roos MTL, Miedema F. Programmed death of T cells in human immunodeficiency virus infection. J Clin Invest 1994;93:982-988.
23. Rotter V, Aloni-Grinstein R, Schwartz D, et al. Does wildtype p53 play a role in normal cell differentiation? Semin Cancer Biol 1994;5:229-236.
24. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MTF, Danska JS. V(D)J recombination activates a p53-dependent DNA damage checkpoint in SCID lymphocyte precursors. Genes Dev 1996;10:2038-2054.